Guardian Pharmacy Services, Inc.
GRDN
$33.66
-$0.44-1.28%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.93% | 18.68% | 18.53% | 19.54% | 17.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.93% | 18.68% | 18.53% | 19.54% | 17.42% |
| Cost of Revenue | 17.47% | 18.77% | 18.97% | 19.55% | 17.44% |
| Gross Profit | 19.78% | 18.32% | 16.72% | 19.52% | 17.31% |
| SG&A Expenses | -30.36% | -20.62% | 97.92% | 116.17% | 111.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.17% | 10.01% | 31.06% | 33.39% | 31.25% |
| Operating Income | 234.07% | 265.34% | -198.57% | -183.78% | -193.40% |
| Income Before Tax | 210.45% | 185.92% | -308.89% | -258.83% | -276.24% |
| Income Tax Expenses | 436.98% | 10,701.70% | -- | -- | -- |
| Earnings from Continuing Operations | 168.92% | 157.87% | -348.72% | -281.93% | -288.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 101.61% | 103.73% | 61.25% | 16.63% | -17.63% |
| Net Income | 156.39% | 146.14% | -681.55% | -450.66% | -465.19% |
| EBIT | 234.07% | 265.34% | -198.57% | -183.78% | -193.40% |
| EBITDA | 355.04% | 571.23% | -149.11% | -142.57% | -148.86% |
| EPS Basic | 143.75% | 117.35% | -883.72% | -- | -- |
| Normalized Basic EPS | 186.22% | 156.65% | -950.75% | -- | -- |
| EPS Diluted | 143.22% | 116.86% | -885.86% | -- | -- |
| Normalized Diluted EPS | 185.02% | 155.74% | -958.09% | -- | -- |
| Average Basic Shares Outstanding | 35.37% | 103.01% | 304.42% | -- | -- |
| Average Diluted Shares Outstanding | 36.84% | 106.30% | 308.85% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -1.05% | -1.21% | -1.26% |